Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Market indices provide a snapshot of broad performance and risk. This overview outlines why investors rely on them for benchmarking.
28,391 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
A big-name hedge fund recently disclosed a fresh stake in a leading utility company, adding roughly 1.9 million share...
Travel rewards can lose value in minutes if you move points without a locked-in stay. This report explains the risk a...
Broadcom stock is bouncing higher as the company rides a wave of AI and data-center demand. This in-depth guide break...
A major auto parts distributor faced a sharp stock pullback while earnings declined. This guide breaks down what that...
A growing share of homeowners won’t sell price—and that stance is reshaping markets. This article explains how small ...
A new deal could amplify AMD's growth path by tying AI memory optimization to data-center demand. Learn why this acqu...
Eagle Point Credit Corp. slashed its monthly distribution in April 2026 after a sharp NAV decline, spotlighting the r...
A once-tiny energy startup sparked a rally after finally showing a profitable revenue stream through an acquired subs...
As AI use expands from training to real-world deployment, memory players like Micron face a pivotal moment. This arti...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...
Meta Platforms surprised the market on Wednesday as investors rallied around news of new paid tier options and a broa...